Gloria Fann
Gloria Fann

Acute Pulmonary Exacerbations Present Inherent Clinical Challenges, For Now

By Gloria Fann, M.D.

The chronic, progressive presentation of COPD, symptom overlap, and nature of patient self-reporting make it hard to identify exacerbations. We need more specific guidelines around, as well as tools for, assessing a patient’s progression from day to day. AI-supported diagnostic systems represent a potential breakthrough technology that could help us overcome significant knowledge gaps.

Continue reading

Rama Chellappa
Rama Chellappa

Instilling Trust in AI

Rama Chellappa, PhD, John Hopkins University Bloomberg Distinguished Professor in electrical, computer, and biomedical engineering, and co-author of “Can We Trust AI?” looks at the promise of AI in health care and how we can best utilize this extraordinary tool to save lives and improve health equity.

Continue reading

Vijay Parmar
Vijay Parmar

Microbattery Advancements Will Unlock a New Wave of MedTech Innovation

By Vijay Parmar

Microbatteries are on the cusp of a new era as solid-state lithium technology arrives to pack more energy into smaller form factors. These batteries will enable the products they power to be offered in smaller sizes and more comfortable shapes, with enormous implications for future medtech product designs and capabilities, from the convergence of hearables and OTC hearing aids to wearable devices that are used for remote health monitoring and fitness tracking.

Continue reading

Simon Johns
Simon Johns
Soapbox

Pharma Needs a New Class of CRM Solutions

By Simon Johns

Companies must have the right data infrastructure in place to help them determine what their customers want, when they want it and how they want to receive it. One of the most critical elements of this success is connected intelligence, which provides a full view of customer needs and expectations to everyone in the organization.

Continue reading

Mike Noshay
Mike Noshay

The Perils of Biased Data

By Mike Noshay

The reality of biased data is becoming all too clear, which raises important questions for clinicians as well as device and drug developers. In a world full of biased data what are the most ethical practices to achieve equitable health care?

Continue reading